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Abstract
To evaluate the predominant human adenovirus (HAdV) species and types associated with
pediatric respiratory infections, nasopharyngeal swabs were collected from otherwise
healthy children attending an emergency room in Milan, Italy, due to a respiratory tract infec-
tion from January 1 to February 28 of two subsequent years, 2013 and 2014. The HAdVs
were detected using a respiratory virus panel fast assay (xTAG RVP FAST v2) and with a
HAdV-specific real-time polymerase chain reaction; their nucleotides were sequenced, and
they were tested for positive selection. Among 307 nasopharyngeal samples, 61 (19.9%)
tested positive for HAdV. HAdV was the only virus detected in 31/61 (50.8%) cases,
whereas it was found in association with one other virus in 25 (41.0%) cases and with two or
more viruses in 5 (8.2%) cases. Human Enterovirus/human rhinovirus and respiratory syn-
cytial virus were the most common co-infecting viral agents and were found in 12 (19.7%)
and 7 (11.5%) samples, respectively. Overall, the HAdV strain sequences analyzed were
highly conserved. In comparison to HAdV-negative children, those infected with HAdV had
a reduced frequency of lower respiratory tract involvement (36.1% vs 55.2%; p = 0.007),
wheezing (0.0% vs 12.5%; p = 0.004), and hospitalization (27.9% vs 56.1%; p<0.001). Anti-
biotic therapy and white blood cell counts were more frequently prescribed (91.9% vs
57.1%; p = 0.04) and higher (17,244 ± 7,737 vs 9,565 ± 3,211 cells/μL; p = 0.04), respec-
tively, in children infected by HAdV-C than among those infected by HAdV-B. On the con-
trary, those infected by HAdV-B had more frequently lower respiratory tract involvement
(57.1% vs 29.7%) but difference did not reach statistical significant (p = 0.21). Children with
high viral load were absent from child care attendance for a longer period of time (14.5 ± 7.5
vs 5.5 ± 3.2 days; p = 0.002) and had higher C reactive protein levels (41.3 ± 78.5 vs 5.4 ±
9.6 μg/dL; p = 0.03). This study has shown that HAdV infections are diagnosed more com-
monly than usually thought and that HAdVs are stable infectious agents that do not
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frequently cause severe diseases. A trend toward more complex disease in cases due to
HAdV species C and in those with higher viral load was demonstrated. However, further
studies are needed to clarify factors contributing to disease severity to understand how to
develop adequate preventive and therapeutic measures.
Introduction
Human adenoviruses (HAdVs) are a group of at least 68 non-enveloped viruses containing
double-stranded linear DNA [1]. They belong to the family Adenoviridae, genusMastadeno-
virus and are categorized into seven species (A-G) according to their biophysical, biochemical,
and genetic characteristics. Moreover, in each of these species, several types have been identi-
fied [1]. Species identity strongly correlates with antigenicity, epidemiologic characteristics,
clinical manifestations of HAdV infection, and in vitro response to some antiviral drugs [2, 3].
From a clinical point of view, species D (HAdV-D8, HAdV-D19, and HAdV-D37) is usually
associated with the development of conjunctivitis; species F (HAdV-F40 and HAdV-F41) is
usually associated with gastroenteritis; and species B (HAdV-B3 and HAdV-B7), C (HAdV-
C1, HAdV-C2, and HAdV-C5), and E (HAdV-E4) are usually associated with respiratory dis-
eases [2]. Recombination between members of the same species and between members of dif-
ferent species has been frequently described [4]. As a result, certain new types may acquire
different pathogenicity and have strong potential for widespread and epidemic outbreaks. Con-
sequently, surveillance of HAdV circulation with an early evaluation of the relationships
between clinical manifestations and molecular characteristics of new infecting strains may be
important for the development of adequate diagnostic, prophylactic, and therapeutic measures
against HAdV infection.
HAdVs play an important role in the determination of respiratory infections, particularly in
children. HAdVs are responsible for a number of lower respiratory tract diseases in children,
including community-acquired pneumonia (CAP). Wo et al. reported that among 3,089 naso-
pharyngeal aspirates collected in children with CAP in China, 186 (6.0%) tested positive for
HAdV [5]. Although HAdVs are associated with mild to moderate disease in most cases, life-
threatening disease can occur in some patients, particularly if they are immunocompromised,
[2]. Overall, little data on HAdV circulation have been collected in Europe and no recent data
regarding the epidemiology, molecular characterization, and clinical features of respiratory
HAdV infections in children have been collected in Italy. The main aim of this study was to
evaluate the predominant HAdV species and types associated with pediatric respiratory infec-
tions in Milan, Italy, during two consecutive winter seasons. Clinical features related to HAdV
types and genetic characteristics were also studied.
Methods
Study design
To evaluate the circulation of the different HAdV types and the possible relationship between
viral load, viral genetic characteristics, and the severity of infection, nasopharyngeal swabs
were collected from otherwise healthy children consecutively attending the Emergency Room
of the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan,
Italy, due to a respiratory tract infection. The study was carried out during the period from Jan-
uary 1 to February 28 in two subsequent years, 2013 and 2014, and was approved by the Ethics
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Committee of the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy.
Written informed consent from a parent or legal guardian was required, and children8 years
of age were asked to give their written assent.
Patient demographic characteristics and medical histories were systematically recorded
before the visit to the Emergency Room using standardized written questionnaires. The study
patients were classified into disease groups (i.e., acute otitis media, rhinosinusitis, pharyngitis,
croup, infectious wheezing, acute bronchitis, pneumonia) on the basis of signs and/or symp-
toms using well-established criteria and were subdivided into two subgroups: upper respiratory
tract infections (URTIs) and lower respiratory tract infections (LRTIs) [6]. Nasopharyngeal
secretions were collected from all of the children immediately after admission to the Emer-
gency Room using a paranasal flocked swab (1 swab per child), which was stored in a tube con-
taining 1 mL of universal transport medium (Kit Cat. No. 360c, Copan Italia, Brescia, Italy).
Respiratory virus identification
Viral nucleic acids were extracted from the swab by means of a Nuclisens EasyMAG automated
extraction system (Biomeriéux, Craponne, France), and the extract was tested for respiratory
viruses using the respiratory virus panel (xTAG RVP Fast v2) (Luminex Molecular Diagnostics,
Inc., Toronto, Canada) fast assay in accordance with the manufacturer’s instructions (Luminex
Molecular Diagnostics Inc.) This assay simultaneously detects the following viruses: influenza
A virus (FluA subtypes H1 or H3); influenza B virus (FluB); respiratory syncytial virus (RSV);
parainfluenzaviruses (HPiV) 1–4; adenoviruses (HAdV); human metapneumovirus (hMPV);
coronaviruses (hCoV) -229E, -NL63, -OC43, and -HKU1; enterovirus/rhinovirus (HEV/HRV)
and human bocavirus (hBoV). Moreover, considering the risk of false negative results reported
for the RVP Fast v2 Assay [7], the negative samples were also tested with an alternative HAdV-
specific real time-PCR [8]. Positive results were also quantified with a HAdV-specific real-time
polymerase chain reaction (PCR), as previously described [9].
Viral nucleic acid extracts were tested using a specific HAdV plasmid by a single-plex real-
time PCR using TaqMan Universal Master Mix II (Applied Biosystems, Foster City, California,
USA). Amplification and detection of viral DNA was performed with a 7900HT real-time PCR
system instrument (Applied Biosystems). The real-time HAdV-specific primer sequences were
as follows: 5’-GCCACGGTGGGGTTTCTAAACTT-3’, Adenoquant 1 (AQ1) and 5’-GCCCC
AGTGGTCTTACATGCACATC-3’, Adenoquant 2 (AQ2). The sequence of the probe was 5’-
TGCACCAGACCCGGGCTCAGGTACTCCGA-3’ (Adenoprobe) labeled with FAM on the 5’-
end as a fluorescent dye and labeled with TAMRA on the 3’-end as a fluorescence quencher
dye. Cycling conditions were as follows: 50°C for 2 min, 95°C for 8 min and 50 cycles of 95°C
for 15 sec and 59°C for 1 min. The plasmid amplified target fragment was verified by sequenc-
ing [7]. Plasmid DNA concentrations were detected using an ND-1000 spectrophotometer
(NanoDrop products, Wilmington, DE).
Real-time fluorescence quantitative PCR was carried out in a total reaction volume of 20 μL
consisting of 10 μL of TaqMan Universal Master Mix (Applied Biosystems), 0.8 μL (0.4 mM)
of each primer, 0.6 μL (0.3 mM) of the probe, 5 μL of template, and 2.8 μL of double-distilled
water. The real-time PCR thermal cycling reaction and quantitative measurement were per-
formed in a StepOne real-time PCR instrument (Applied Biosystems) using the following con-
ditions: one cycle at 50°C for 2 min, one cycle at 95°C for 10 min, 45 cycles at 95°C for 15 s,
and one cycle at 60°C for 1 min [9]. Each run included plasmid and negative controls. Standard
precautions were taken throughout the PCR process to avoid cross-contamination. Negative
controls and serial dilutions of the plasmid positive control were included in every PCR assay.
Finally, quantitative results were reported as DNA copies/mL of respiratory samples.
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HAdV sequencing
HAdV typing was performed by sequencing the hypervariable region (1–6) of loop 1 of the
hexon protein using a protocol proposed by Lu and Erdman [10]. PCR products ranging in
size from 764 to 896 bp (first PCR) and 688 to 821 bp (nested PCR). First-round amplification
was carried out using primers for AdhexF1 (nt 19135–19160; 5’-TICTTTGACATICGIGGI
GTICTIGA-3’) and AdhexR1 (nt 20009–20030; 5’-CTGTCIACIGCCTGRTTCCACA-3’)
followed by a nested round of PCR performed using internal primers: AdhexF2 (nt 19165–
19187; 5’-GGYCCYAGYTTYAARCCCTAYTC-3’) and AdhexR2 (nt 19960–19985; 5’-
GGTTCTGTCICCCAGAGARTCIAGCA-3’). PCR amplification was performed in a 50 μL
reaction containing 45 μL of reaction mixture (10 mM Tris-HCl [pH 8.3], 1.5 mM of MgCl2,
50 mM KCl, 200 μM of each deoxynucleotide triphosphate, 0.2 μM of each primer, 1 U of Taq
DNA polymerase [Roche Diagnostics, Indionapolis, IN]) and 5 μL of nucleic acid extract on a
GeneAmp PCR System 9700 (Applied Biosystems) with the following settings: 94°C for 2 min
denaturation followed by 35 cycles of 94°C for 1 min, 45°C for 1 min, and 72°C for 2 min, with
a final extension of 72°C for 5 min. For the nested reaction, 0.5 μL of the first PCR product was
amplified as above. Amplified products were separated on 1% agarose gels and purified with
the QIAquick PCR Purification Kit (Qiagen, Chatsworth, California, USA). Sequencing was
performed in both directions using AdhexF2/AdhexR2 primers and the ABI Prism BigdyeTM
Terminator Cycle Sequencing Ready Reaction Kit Ver. 3.1 on an ABI 3100 DNA Sequencer
(Applied Biosystems).
Sequencher 3.1.1 software (Gene Codes, Ann Arbor, Minnesota, USA) was used for
sequence assembly and editing. All sequences were aligned using ClustalX 2.1 and BioEdit (ver-
sion 7.1.3.0) software (Ibis Biosciences, Carlsbad, California, USA). Phylogenetic trees were
generated using the Maximum likelihood method with Molecular Evolutionary Genetics Anal-
yses (MEGA) software, version 5.05 [11], and Adenovirus prototype strains. Bootstrap proba-
bilities for 1,000 iterations were calculated to evaluate confidence estimates. The graphs were
made using GraphPad Prism version 5.01 for Windows (GraphPAD Software, San Diego, Cali-
fornia, USA). All the HAdV sequences originated from this study were submitted to GenBank
(accession numbers KT963953-KT964000).
Statistical analysis
Descriptive statistics of the responses were generated. Continuous variables were presented as
the mean values and standard deviations (SDs), and categorical variables were presented as
numbers and percentages. For categorical data, comparisons between groups were performed
using a contingency table analysis with a χ2 or Fisher’s exact test when appropriate. For ordered
categorical data, a Cochran-Armitage test for trends was used to compare the groups. Continu-
ous data were analyzed using a two-sided Student’s t-test after ensuring the data were normally
distributed (based on the Shapiro-Wilk statistic) or using a two-sided Wilcoxon’s rank-sum
test if the data were non-normal. All analyses were two tailed, and p-values of 0.05 or less were
considered to be statistically significant. All analyses were conducted using SAS version 9.2
(Cary, NC, USA).
Results
HAdV incidence and phylogenetic analyses
During the two study periods, a total of 307 nasopharyngeal samples were collected in the
emergency room. Of these, 61 (19.9%) tested positive for HAdV. The Luminex xTAG RVP
Fast v2 assay identified 30 cases, all confirmed by real-time PCR. This method revealed 31
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positive cases that tested negative with the RVP Fast V2 assay. Among the HAdV infected chil-
dren, 14.8% were<1 year old, whereas 42.6% and 42.6% were 1–2 and3 years old, respec-
tively (Table 1).
The prevalence of HAdV detection was similar in the two studied periods: 28 (45.9%) and
33 (54.1%) positive samples were collected in 2013 and 2014, respectively. HAdV was the only
virus detected in 31/61 (50.8%) cases, whereas it was found in association with one other virus
in 25 (41.0%) cases and with two or more viruses in 5 (8.2%) cases. HEV/HRV and RSV were
the most common co-infecting viral agents and were found in 12 (19.7%) and 7 (11.5%) sam-
ples, respectively.
Molecular typing assignments were based on the identity of the closest matching sequences
after both BLAST and phylogenetic analysis. The 61 HAdVs belonged to species B in 7 cases
(11.5%; all HAdV-B3), species C in 37 cases (60.7%; 10 HAdV-C1, 25 HAdV-C2, and 2
HAdV-C5), species D in 1 case (1.7%; HAdV-D26), species E in 2 cases (3.4%; HAdV-E4), and
species F in 1 case (1.6%; HAdV-F41) (Fig 1). It was not possible to identify the species and
type of 13 (18.6%) samples due to inadequate sample volume.
No peculiar clustering was observed among HAdV strains. HAdVs circulating in 2013 were
closely related to strains identified in 2014. However, among HAdV-C2 sequences, two distinc-
tive branches were observed with 15 and 10 Italian strains (Fig 1). Similarly, in the branch of
the tree corresponding to the HAdV-C1 strains, two strains appeared to cluster separately
from the other 8 strains.
Viral load
Using 106 DNA copies/mL as a cut-off, the viral load was classified as low in 37 (62.7%) and as
high in 22 (37.3%) cases (2 HAdV-B, 14 HAdV-C, and 7 of 11 without species identification).
For HAdV-B, viral load varied from 1.4 x 102 to 3.9 x 108 copies/mL, whereas for HAdV-C it
was between 3.4 x 103 and 3.0 x 109 copies/mL. No significant difference in viral load was
observed between each HAdV species
The sequence identity matrix of the HAdV partial hexon gene for groups with at least 7
sequences (HAdV-C2, -C1 and -B3) showed a minimum to maximum identity range of 97.6–
100.0% for HAdV-C2, 98.7–100% for HAdV-C1, and 99.4–100% for HAdV-B3.
Overall, the HAdV strain sequences analyzed were highly conserved and only few amino
acid changes were observed. In detail, among the HAdV-C2 sequences, 15/25 strains (60.0%)
had an insertion of one glutamic acid (E) in position 151 and the M305L change. In two of
Table 1. Number of children tested positive for human adenovirus (HAdV) with respiratory tract infection across different age groups, according
to species and viral load.
No. (%) of positive samples
Age group (years) Overall Species B Species C Other species Low viral load High viral load
< 1 9 (14.8) 2 (28.6) 7 (18.9) 0 (0.0) 5 (13.5) 4 (18.2)
1–2 26 (42.6) 2 (28.6) 17 (45.9) 2 (50.0) 14 (37.8) 10 (45.4)
 3 26 (42.6) 3 (42.8) 13 (35.2) 2 (50.0) 18 (48.7) 8 (36.4)
Total 61 7 37 4 37 22
Serotype was not available for 13 positive subjects, and viral load was not available for 2 positive subjects. Viral load was categorized in two groups and
was considered “low” for values <6 log(copies/mL) and “high” for values 6 log(copies/mL). No statistically signiﬁcant result emerged for the relationship
between adenovirus types and age or between viral load and age.
doi:10.1371/journal.pone.0152375.t001
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these strains, the additional change S195T was identified. Among the HAdV-C1 sequences,
only one amino acid change (A190T) was evidenced in 2/10 strains (20.0%). Finally, in 5/7
strains (71.4%) belonging to the HAdV-B3 group, two changes, G205V and T254I, were
observed.
Fig 1. Phylogenetic tree based on partial hexon gene sequences of HAdV strains. Sequences originated from this study are indicated with black circles.
HAdV reference stains are in bold. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is
shown next to the branches.
doi:10.1371/journal.pone.0152375.g001
Adenovirus Species and Types Circulation
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Clinical characteristics of HAdV infection
In Table 2, demographic, clinical, and laboratory characteristics of children infected by HAdV
alone or co-infected with HAdV and one or more other respiratory viruses are compared with
those of children with respiratory infection due to other agents. A preliminary analysis revealed
that no statistically significant difference between cases infected by HAdV alone or co-infected
with other viruses, in particular RSV or Rhinovirus could be evidenced, all the children with
HAdV infection were considered together. As shown, in comparison to HAdV-negative chil-
dren, those infected with HAdV were younger (4.3 ± 3.3 vs 3.2 ± 2.5 years; p = 0.01) and had
high-grade fever more frequently (56.4% vs 72.4%; p = 0.03). Moreover, children infected with
HAdV had lower respiratory tract involvement less frequently (55.2% vs 36.1%; p = 0.007) and
never suffered from wheezing unlike children with disease due to other etiologic agents.
Table 2. Comparison between subjects who tested positive and those who tested negative for human adenovirus (HAdV), according to demo-
graphic, clinical, and laboratory variablesa.
Characteristic HAdV-negative N = 248 HAdV-positive N = 61 P value for comparison
n/N (%) n/N (%)
Demographic and clinical presentation
Males (%) 143/244 (58.6) 29/60 (48.3) 0.15
Mean age ± SD, yrs 4.3 ± 3.3 3.2 ± 2.5 0.01
Presence of fever” (%) 211/220 (95.9) 56/58 (96.6) 0.99
High-grade fever° (%) 124/220 (56.4) 42/58 (72.4) 0.03
Respiratory rate, breaths/min 37.0 ± 11.7 34.7 ± 9.9 0.41
SpO2 in room air, mean % ± SD 97.2 ± 2.4 97.8 ± 1.9 0.17
Clinical ﬁndings
Cough 180/236 (76.3) 43/60 (71.7) 0.46
Rhonchi 25/239 (10.5) 2/61 (3.3) 0.08
Rales 108/240 (45.0) 21/61 (34.4) 0.14
Wheezes 30/240 (12.5) 0/61 (0.0) 0.004
Diagnosis
Upper respiratory tract infection 111/248 (44.8) 39/61 (63.9)
Lower respiratory tract infection 137/248 (55.2) 22/61 (36.1) 0.007
Clinical outcome
Hospitalization rate, no.(%) 139/248 (56.1) 17/61 (27.9) <0.001
Drug use, no. (%)
Antibiotics 225/248 (90.7) 53/61 (86.9) 0.37
Antipyretics 101/111 (91.0) 43/46 (93.5) 0.76
Aerosol therapy 48/111 (43.2) 14/46 (30.4) 0.14
Absence from child care attendance 6.1 ± 3.3 9.1 ± 7.0 0.07
mean days ± SD
Similar illness within the households 45/111 (40.5) 16/48 (33.3) 0.39
Laboratory data
White blood cell count (cells/μL) 14,589 ± 8,255 15,381 ± 7,461 0.40
Neutrophils, % 63.4 ± 19.9 60.3 ± 17.0 0.27
CRP, μg/dL 12.2 ± 25.8 23.3 ± 53.9 0.40
CRP, C reactive protein; SD, standard deviation; SpO2, peripheral oxygen saturation.”38.0°C or more any time during the illness (before or at enrolment,
or during follow-up); °39.0°C or more any time during the illness (before or at enrollment or during follow-up).
a Data were extracted from datasets of different studies that collected different information; therefore, the denominators vary across characteristics.
However, when not indicated the reported number refers to the whole enrolled sample.
doi:10.1371/journal.pone.0152375.t002
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Children infected with other agents wheezed in 12.5% of the cases (p = 0.004) and were hospi-
talized more frequently (56.1% vs 27.9%; p<0.001). No other significant differences between
groups were observed.
In Table 3, comparisons based on demographic, clinical, and laboratory variables between
subjects with HAdV B and C species are shown. Two significant differences were found
between the groups: antibiotic therapy was more frequently prescribed (91.9% vs 57.1%;
p = 0.04) and white blood cell count was higher (17,244 ± 7,737 vs 9,565 ± 3,211; p = 0.04) in
children infected by HAdV-C.
Table 4 shows data regarding characteristics of children with HAdV infection according to
viral load. Children with high viral load were younger, had high-grade fever more frequently,
were more frequently hospitalized, were absent from the community for a longer period of
time, and had a higher C reactive protein (CRP) level. However, differences were statistically
Table 3. Comparison between subjects with human adenovirus (HAdV) species B and C, according to demographic, clinical, and laboratory
variablesa.
Characteristic HAdV-B species N = 7 HAdV-C species N = 37 P value for comparison
n/N (%) n/N (%)
Demographic and clinical presentation
Males (%) 4/7 (57.1) 19/36 (52.8) 0.99
Mean age ± SD, yrs 3.0 ± 1.9 2.8 ± 2.4 0.82
Presence of fever” (%) 5/5 (100.0) 34/36 (94.4) 0.99
High-grade fever° (%) 5/5 (100.0) 26/36 (72.2) 0.31
Respiratory rate, breaths/min 39.2 ± 8.5 34.9 ± 10.7 0.23
SpO2 in room air, mean % ± SD 96.6 ± 3.7 97.9 ± 1.8 0.61
Clinical ﬁndings
Cough 4/7 (57.1) 25/37 (67.6) 0.67
Rhonchi 0/7 (0.0) 0/37 (0.0) -
Rales 3/7 (42.9) 11/37 (29.7) 0.66
Wheezes 0/7 (0.0) 0/37 (0.0) -
Diagnosis
Upper respiratory tract infection 3/7 (42.9) 26/37 (70.3)
Lower respiratory tract infection 4/7 (57.1) 11/37 (29.7) 0.21
Clinical outcome
Hospitalization rate, no.(%) 3/7 (42.9) 9/37 (24.3) 0.37
Drug use, no. (%)
Antibiotics 4/7 (57.1) 34/37 (91.9) 0.04
Antipyretics 3/4 (75.0) 27/29 (93.1) 0.33
Aerosol therapy 1/4 (25.0) 10/29 (34.5) 0.99
Absence from child care attendance, mean days ± SD 4.5 ± 0.7 9.6 ± 7.8 0.37
Similar illness within the households 1/5 (20.0) 13/30 (43.3) 0.63
Laboratory data
White blood cell count (cells/μL) 9,565 ± 3,211 17,244 ±7,737 0.04
Neutrophils, % 57.6 ± 6.8 61.1 ± 17.8 0.99
CRP, μg/dL 5.9 ± 7.1 27.4 ± 69.7 0.87
CRP, C reactive protein; SD, standard deviation; SpO2, peripheral oxygen saturation.”38.0°C or more any time during the illness (before or at enrolment,
or during follow-up); °39.0°C or more any time during the illness (before or at enrollment or during follow-up).
aData were extracted from datasets of different studies that collected different information; therefore, the denominators vary across characteristics.
However, when not indicated the reported number refers to the whole enrolled sample.
doi:10.1371/journal.pone.0152375.t003
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significant only for absence from the community (14.5 ± 7.5 vs 5.5 ± 3.2 days; p = 0.002) and
CRP level (41.3 ± 78.5 vs 5.4 ± 9.6 μg/dL; p = 0.03).
Discussion
Several previous epidemiological studies have shown that HAdVs are considered the cause of
respiratory infections in otherwise healthy children in approximately 4–10% of the cases [12–
15]. In this study, similarly to what has been found in Asia by other authors [16], a prevalence
of approximately 20% was found, suggesting that the relevance of this infectious agent in the
determination of respiratory problems could be higher than previously thought. The methods
used to identify HAdVs might partially explain this finding. In the past, most of the
Table 4. Comparison between subjects with low and high viral load, according to demographic, clinical and laboratory variablesa.
Characteristic Low viral load, <6 log(copies/mL)
N = 37




n/N (%) n/N (%)
Demographic and clinical presentation
Males (%) 18/36 (50.0) 11/22 (50.0) 0.99
Mean age ± SD, yrs 3.4 ± 2.3 2.8 ± 2.7 0.16
Presence of fever” (%) 34/36 (94.4) 20/20 (100.0) 0.53
High-grade fever° (%) 25/36 (69.4) 16/20 (80.0) 0.39
Respiratory rate, breaths/min 34.6 ± 9.6 35.0 ± 11.1 0.99
SpO2 in room air, mean % ± SD 97.9 ± 1.4 97.5 ± 2.8 0.88
Clinical ﬁndings
Cough 26/37 (70.3) 15/21 (71.4) 0.93
Rhonchi 1/37 (2.7) 0/22 (0.0) 0.99
Rales 10/37 (27.0) 10/22 (45.4) 0.15
Wheezes 0/37 (0.0) 0/22 (0.0) -
Diagnosis
Upper respiratory tract infection 27/37 (73.0) 12/22 (54.5)
Lower respiratory tract infection 10/37 (27.0) 10/22 (45.4) 0.15
Clinical outcome
Hospitalization rate, no.(%) 8/37 (21.6) 8/22 (36.4) 0.22
Drug use, no. (%)
Antibiotics 31/37 (83.8) 20/22 (90.9) 0.70
Antipyretics 27/29 (93.1) 14/15 (93.3) 0.99
Aerosol therapy 7/29 (24.1) 7/15 (46.7) 0.18
Absence from child care attendance, mean
days ± SD
5.5 ± 3.2 14.5 ± 7.5 0.002
Similar illness within the family 10/29 (34.5) 5/17 (29.4) 0.72
Laboratory data
White blood cell count (cells/μL) 13,575 ± 7,624 15,891 ± 6,888 0.49
Neutrophils, % 62.6 ± 20.4 56.7 ± 13.5 0.38
CRP, μg/dL 5.4 ± 9.6 41.3 ± 78.5 0.03
CRP, C reactive protein; SD, standard deviation; SpO2, peripheral oxygen saturation.”38.0°C or more any time during the illness (before or at enrollment
or during follow-up); °39.0°C or more any time during the illness (before or at enrollment or during follow-up).
aData were extracted from datasets of different studies that collected different information; therefore, the denominators vary across characteristics.
However, when not indicated the reported number refers to the whole enrolled sample
doi:10.1371/journal.pone.0152375.t004
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epidemiological studies of viral respiratory infections were carried out using methods that
could underestimate viral presence in respiratory secretions, such as viral culture, antigen
detection by immunofluorescence, and visualization by electron microscopy [17]. To overcome
this problem, molecular methods were suggested. Multiplex assays, including the RVP Fast v2
assay, were developed to obtain the simultaneous identification of all the most common respi-
ratory viruses and are now commonly used in routine practice. As previously reported [8] and
confirmed by this study, the RVP Fast v2 assay has poor sensitivity for HAdV and can lead to
undervaluation of the real importance of these viruses in the determination of respiratory
infections. The addition of a specific real-time PCR can solve this issue.
Moreover, the higher than expected prevalence of HAdV infection evidenced by this study
could be strictly related to the period during which it was carried out. Samples were collected
in two winter months of two consecutive years. Although HAdVs circulate during the whole
year, peak periods are in winter and early spring [1]. Consequently, it is possible that the study
was carried out during epidemics leading to the higher prevalence values reported here.
In this study, the most commonly identified species were B and C, types 3, 2, and 1. This is
not surprising because, despite possible temporal and regional changes in predominant type
[18], these types are more commonly reported as the cause of respiratory infection worldwide.
HAdV-B3 has been identified in successive outbreaks of severe acute respiratory illnesses in
Korea [19, 20], Brazil [21], and Taiwan [22, 23], where this virus was the predominant type for
respiratory HAdV infection from 1981 to 2002. Moreover, together with other HAdV types, it
has been the causative agent in epidemic outbreaks of respiratory diseases in Europe, America,
and Oceania [24–26]. Finally, HAdV-B3 is known to be a causative agent of a characteristic
syndrome of acute pharyngo-conjunctival fever in older children and adults, especially in sum-
mer camps and swimming pools [27]. Types C1 and C2 have been more frequently reported as
the cause of endemic or sporadic cases [28], although there have been reports of epidemics
[19]. In Italy, a survey carried out approximately 10 years ago found that HAdV-C1 and -C2
were the most common HAdVs isolated in patients with infection due to these agents [28]. The
same was shown by this study, showing that epidemics of infection due to the same HAdV in a
given geographic area can be prolonged compared with outbreaks of RSV, parainfluenza virus,
and influenza viruses, which are well defined and have duration limited to some months [29,
30].
The severity of HAdV infection varies according to age, socioeconomic status, environmen-
tal status, and above all, the immunological characteristics of the patient. Detection of HAdV
in severely immunocompromised children has been implicated as a risk factor for poor out-
come [31]. However, severe cases have been frequently described in otherwise healthy children
[5, 19, 20]. In this study, most of the children with HAdV infection had a mild infection and,
globally, the severity of respiratory infection of children in whom HAdV alone or in association
with other respiratory viruses was identified was lower than that due to other infectious agents
considered together. Both the prevalence of LRTIs and hospitalization rate were significantly
lower in HAdV-infected children than in children not infected by HAdV. The long-term circu-
lation of HAdVs with similar genetic characteristics could partially explain the generally poor
clinical relevance of infections due to the strains identified in this study. In Italy, the most com-
mon HAdVs identified in children during the periods of this study were of the same species
and of the same types of those identified several years before. Moreover, despite sequencing
analyses that were focused on one of the more variable genes (hexon) [32], no significant varia-
tion in HAdV genetic characteristics was seen and no recombination between viruses was
found. HAdV-C2 strains were the only strains to have two slightly different clusters, suggesting
the circulation of two different HAdV-C2 strains with indistinct pathogenetic roles. As a result,
it is possible that many of the children had previously had contact with these viruses and
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developed sufficiently high immunity to limit the clinical expression of subsequent infections.
However, the number of non-HAdV infection children included in this study is significantly
higher than that of HAdV infected patients and this difference could have led comparison to
wrong results. A longer period and expanded surveillance may help to construct the complete
picture on the HAdV circulation, other infections and related clinical features.
Prevalence of LRTI was higher in children infected by type B3, although the difference com-
pared with type C was not statistically significant and the total number of patients with this
type of infection is too small to draw definitive conclusions. Potentially increased virulence of
type B3 in comparison to other HAdVs is not surprising because this virus has already been
associated with a number of severe LRTIs [5, 19, 20] and to the development of acute
meningo-encephalopathy [33].
In this study, higher viral load was more common in children with some markers of more
severe disease, such as higher fever, higher hospitalization rate, higher CRP values, and delayed
return to normal activities, independent of the infecting HAdV type. However, clinical differ-
ences between patients with high or low viral load were not always significant, and it is not pos-
sible to state that HAdV load can be a marker for severity of infection. By contrast, HAdV load
was found to be significantly higher in patients developing severe HAdV infection after trans-
plantation, especially in pediatric stem cell transplant recipients [31]. Consequently, the mea-
surement of HAdV load is considered a possible method for an early diagnosis of disseminated
HAdV disease and for the initiation and monitoring of antiviral therapy in these subjects [34].
Further studies are needed to evaluate whether high viral load could indicate which subjects
might have to receive antiviral therapy to avoid negative evolution of the infection even if they
are not immunocompromised.
In conclusion, this study has shown that when adequately investigated, HAdV infections
are diagnosed more commonly than usually thought. Moreover, these data seem to indicate
that HAdVs are stable infectious agents that do not frequently incur genetic variations and, for
this reason, do not cause frequently severe diseases. It seems that there are some differences in
the severity of disease outcome between types and according to viral load, with HAdV type C
and high viral load apparently associated with a more severe disease. However, further studies
are needed to identify the potential pathogenetic role of the different species and types of
HAdV and the importance of viral load in the severity of infection. Clarification of these
unsolved problems may be useful for deciding how to develop adequate preventive and thera-
peutic measures for immunocompromised and otherwise healthy children who suffer from
HAdV infection.
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